PMCB (PharmaCyte Biotech) Beta: 1.0434 (As of Jun. 25, 2026)

PharmaCyte Biotech  (NAS:PMCB) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

PharmaCyte Biotech Beta Related Terms

The historical data trend for PharmaCyte Biotech's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaCyte Biotech Beta Chart

PharmaCyte Biotech Annual Data
	Trend	Apr16	Apr17	Apr18	Apr19	Apr20	Apr21	Apr22	Apr23	Apr24	Apr25
Beta		Get a 7-Day Free Trial					-0.25	-0.62	-0.91	0.27	0.73

PharmaCyte Biotech Quarterly Data
	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25	Apr25	Jul25	Oct25	Jan26
Beta	Get a 7-Day Free Trial															0.48	0.73	0.66	0.60	0.71

PMCB vs IMNN, ACXP, ENVB: Beta Comparison

For the Biotechnology subindustry, PharmaCyte Biotech's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmaCyte Biotech Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaCyte Biotech's Beta distribution charts can be found below:

* The bar in red indicates where PharmaCyte Biotech's Beta falls into.

PharmaCyte Biotech Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

PharmaCyte Biotech Business Description